When was Evidation founded?

Evidation was founded in 2012 and raised its 1st funding round within a year of its incorporation.

Where is Evidation located?

Evidation is headquartered in Menlo Park, United States.

Who is the current CEO of Evidation?

Christine Lemke of Evidation. They have also founded 1 company and are an angel investors in 1 startup.

How many employees does Evidation have?

As of Feb 28, 2026, the latest employee count at Evidation is 101.

Is Evidation a funded company?

Evidation is a funded company, having raised a total of $259M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 01, 2012.

When was the latest funding round of Evidation?

Evidation's latest funding was a $***** Grant (prize money) round on Mar 12, 2025, with participation from 1 investor.

Where does Evidation rank among its competitors?

Evidation ranks 1st amongst 164 active competitors, of which 44 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was myTomorrows, which secured $29M in Nov, 2025.

Who are the top competitors of Evidation?

Evidation's top competitors include myTomorrows, SubjectWell and Trialbee. Among them, myTomorrows secured the most recent funding round in November, 2025.

Evidation - 2026 Company Profile, Team, Funding & Competitors

Company Details

Real-world health data insights for better healthcare decisions and research. The company connects directly with individuals to gather real-world health data, providing valuable insights for healthcare and research. They empower individuals to contribute their health data and benefit from its value, fostering a community focused on improving health outcomes. The company partners with organizations across life sciences, healthcare, government, and research to drive discoveries and advance healthcare. They offer solutions for patient insights, recruitment, real-world studies, and data analysis, leveraging diverse data sources like electronic health records, patient-reported outcomes, and data from devices. The company is committed to building trust and transparency, ensuring individuals have control over their data and are rewarded for engaging with their health. Their platform facilitates research and programs across various health conditions, contributing to a deeper understanding of health and disease.

Website: evidation.com
Social
Email ID: *****@evidation.com

Key Metrics

Founded Year

2012

Location

Menlo Park, United States

Stage

Series E

Total Funding

$259M in 8 rounds

Latest Funding Round

Grant (prize money), Mar 12, 2025, $*****

Investors

B Capital & 16 more

Ranked

1^st among 164 active competitors

Employee Count

101 as on Feb 28, 2026

Similar Companies

myTomorrows & 236 more

View Evidation's full profile

Evidation is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
EVIDATION HEALTH INC CIN: T19UF8113G , Singapore, Active	Oct 08, 2019	-	-
EVIDATION HEALTH, INC. CIN: 454887421 , United States, Active	Dec 31, 1999	-	92 (As on Dec 31, 2024)	-

Evidation has raised a total funding of $259M over 8 rounds. Its first funding round was on Jan 01, 2012. Its latest funding round was a Grant (prize money) round on Mar 12, 2025 for $*****. 1 investor participated in its latest round. Evidation has 16 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Evidation:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 12, 2025	3650079	Grant (prize money)	4910006	1977942	1196421	2550532
Mar 22, 2021	6324372	Series E	9322513	5187546	5695003	McKesson & 1 more
Jul 01, 2020	7483104	Series D	1056123	1726218	B Capital	McKesson & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Evidation's funding rounds and investors

The founders of Evidation are Luca Foschini, Christine Lemke, Mikki Nasch and Alessio Signorini. Christine Lemke is the CEO of Evidation.

Here are the details of Evidation's key team members:

Luca Foschini: Former Co-Founder of Evidation and founder of 3 other companies, Kodiak Robotics, The Activity Exchange and AchieveMint. They are also an angel investor in 2 startups.
Contact Info: 2 email addresses
Christine Lemke: Co-founder, CEO of Evidation and founder of 1 other company. They are also an angel investor in 1 startup.
Mikki Nasch: Co-founder of Evidation.
Alessio Signorini: Co-Founder & CTO of Evidation and founder of 2 other companies, Kodiak Robotics and AchieveMint.

Evidation's Board of Directors

Evidation's board has 6 active members. Christine Lemke, Rowan Chapman, Lisa Suennen, David Fleshman, Raj Ganguly and Deborah Kilpatrick are independent board members.

Here is the list of Evidation's board of directors:

Name	Type	Representing	Status	Duration
Christine Lemke	Independent board member	-	Current	11y 1m
cftvivd	Independent board member	-	Current	7y 8m
qkdtqyy	Independent board member	-	Current	8y 3m
xsibstb	Independent board member	-	Current	3y 8m
xgcqxhy	Independent board member	-	Current	3y 5m
{zbcrvl	Independent board member	-	Current	3y 7m

View details of Evidation's Founder profiles and Board Members

Evidation's employee count trend

Evidation has 101 employees as of Feb 26. Here is Evidation's employee count trend over the years:

Uncover Evidation's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Evidation include myTomorrows, SubjectWell and Trialbee. Here is the list of Top 10 competitors of Evidation, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Evidation 2012, Menlo Park (United States), Series E	Real-world health data insights for better healthcare decisions and research	$259M	Cross Creek, G Squared & 15 others	74/100
2nd	myTomorrows 2012, Amsterdam (Netherlands), Series C	Platform provides access to drugs in development to patients and physicians	$51.3M	Sofinnova Investments, Octopus Ventures & 5 others	68/100
3rd	SubjectWell 2012, Austin (United States), Acquired	Provider of clinical trials marketplace offering solutions for patient recruitment	$46.8M	Windham Venture Partners, Asset Management Ventures ... & 10 others	60/100
4th	Trialbee 2010, Malmo (Sweden), Acquired	Cloud based clinical trial recruitment solutions for pharmaceutical companies, analytics, services	$27.1M	MTIP, Industrifonden & 5 others	59/100
5th	Dyania Health 2019, Sacramento (United States), Series A	Developer of an AI platform for healthcare data extraction and analysis	$15.3M	HealthX Ventures, Innospark & 13 others	59/100
6th	Circuit Clinical 2014, Buffalo (United States), Series C	Research site network platform focuses on patient identification, enrollment, recruitment & retention	$47.7M	LabCorp, Rochester Angel Network & 8 others	58/100
7th	Paradigm 2003, New York City (United States), Series A	Provider of clinical research healthcare services	$203M	General Catalyst, Arch Venture Partners & 6 others	56/100
8th	Little Journey 2018, London (United Kingdom), Series A	Provider of digital health solutions for pediatric healthcare	$13.2M	Octopus Ventures, Par Equity & 13 others	55/100
9th	Antidote 2008, London (United Kingdom), Series C	Provider of search engine tool for patients to explore, understand and access clinical trials.	$52M	Octopus Ventures, Merck Global Health Innovation Fund ... & 5 others	55/100
10th	BEKHealth 2016, New York City (United States), Series C	Provider of patient screening, recruitment, and analytics solution	$15.7M	Excelerate Health Ventures, Hatteras Venture Partners ... & 6 others	54/100